Values First Advisors’s LeMaitre Vascular LMAT Stock Holding History

Values First Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.2M	Sell	20,197 -114	-0.6%	-$10.9K	1.15%	21
2025 Q4	$1.65M	Sell	20,311 -870	-4%	-$74.9K	0.85%	38
2025 Q3	$1.85M	Sell	21,181 -170	-0.8%	-$15.2K	0.99%	35
2025 Q2	$1.77M	Sell	21,351 -5,261	-20%	-$440K	0.97%	31
2025 Q1	$2.23M	Buy	26,612 +88	+0.3%	+$8.19K	1.3%	15
2024 Q4	$2.44M	Sell	26,524 -1,216	-4%	-$117K	1.35%	13
2024 Q3	$2.58M	Sell	27,740 -334	-1%	-$28.9K	1.4%	14
2024 Q2	$2.31M	Sell	28,074 -4,895	-15%	-$360K	1.38%	16
2024 Q1	$2.19M	Sell	32,969 -648	-2%	-$40K	1.28%	21
2023 Q4	$1.91M	Buy	33,617 +626	+2%	+$32.8K	1.15%	24
2023 Q3	$1.8M	Sell	32,991 -303	-0.9%	-$18K	1.16%	19
2023 Q2	$2.24M	Sell	33,294 -5,964	-15%	-$364K	1.35%	13
2023 Q1	$2.02M	Buy	39,258 +460	+1%	+$22.3K	1.29%	17
2022 Q4	$1.79M	Sell	38,798 -897	-2%	-$42K	1.25%	21
2022 Q3	$2.01M	Buy	39,695 +1,021	+3%	+$51K	1.45%	13
2022 Q2	$1.76M	Buy	+38,674	New	+$1.73M	1.25%	20

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Values First Advisors's LMAT Position: Q1 2026 in Review

Values First Advisors reduced its LeMaitre Vascular (LMAT) stake by 0.56% in Q1 2026, selling an estimated $10.9K and leaving 20,197 shares worth $2.2M. The position accounts for 1.15% of the portfolio, ranked #21.

Values First Advisors first reported a position in LMAT in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.58M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Values First Advisors held 20,197 shares of LeMaitre Vascular worth $2.2M as of Q1 2026.
Values First Advisors sold 114 LeMaitre Vascular shares in Q1 2026, an estimated $10.9K.
LeMaitre Vascular made up 1.15% of Values First Advisors's portfolio in Q1 2026, its #21 holding.
Values First Advisors first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 16 quarters since.
Values First Advisors's LeMaitre Vascular position peaked at $2.58M in Q3 2024.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.